InvIOs GmbH | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
InvIOs GmbH

BRIEF

published on 12/16/2024 at 15:05, 5 days 4 hours ago

InvIOs to Highlight Oncology Pipeline Progress at JP Morgan Week 2025

Oncology Cancer Research Cell Therapy Glioblastoma InvIOs GmbH
BRIEF

published on 12/16/2024 at 15:05, 5 days 4 hours ago

InvIOs mettra en avant les progrès du pipeline oncologique lors de la JP Morgan Week 2025

Thérapie Cellulaire Oncologie Glioblastome Recherche Sur Le Cancer InvIOs GmbH
PRESS RELEASE

published on 12/16/2024 at 15:00, 5 days 4 hours ago

invIOs to present progress across oncology pipeline during JP Morgan Week 2025
invIOs GmbH to present progress in oncology pipeline at JP Morgan Week 2025, including updates on glioblastoma treatments INV501 and INV441 in collaboration with DFCI

Oncology Pipeline InvIOs GmbH JP Morgan Week 2025 Glioblastoma Treatments DFCI Collaboration
BRIEF

published on 10/15/2024 at 10:35, 2 months 6 days ago

InvIOs Secures €8.2 Million Series A Funding for Immuno-oncology Innovations

Biotechnology Fundraising Clinical Trials Immuno-oncology InvIOs GmbH
BRIEF

published on 10/15/2024 at 10:35, 2 months 6 days ago

InvIOS obtient un financement de série A de 8,2 millions d'euros pour des innovations en immuno-oncologie

Biotechnologie Essais Cliniques Immuno-oncologie Collecte De Fonds InvIOs GmbH
PRESS RELEASE

published on 10/15/2024 at 10:30, 2 months 6 days ago

invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
invIOs GmbH raises €8.2 million in Series A funding to advance immuno-oncology pipeline progress through 2025, collaborating with Dana-Farber Cancer Institute

Series A Funding Immuno-oncology Pipeline Progress InvIOs Dana-Farber Cancer Institute
BRIEF

published on 07/17/2024 at 10:05, 5 months 4 days ago

InvIOs Selects INV501 Lead Candidate for IND-Enabling Studies in Glioblastoma and Melanoma

Cancer Therapy Melanoma Preclinical Studies INV501 Glioblastoma
BRIEF

published on 07/17/2024 at 10:05, 5 months 4 days ago

InvIOs sélectionne le candidat principal INV501 pour des études IND-habilitantes sur le glioblastome et le mélanome

Thérapie Contre Le Cancer Etudes Précliniques Mélanome INV501 Glioblastome
PRESS RELEASE

published on 07/17/2024 at 10:00, 5 months 4 days ago

invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma
invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma. The compound shows strong activation of tumor-specific T cells in preclinical testing

Melanoma IND-enabling Studies INV501 Glioblastoma InvIOs
PRESS RELEASE

published on 11/09/2023 at 11:30, 1 year 1 month ago

invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 58 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 58 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 23 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 28 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 58 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 37 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 43 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 10 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 10 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE